Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Davunetide intravenous

Next Previous
Drug Profile

Davunetide intravenous

Alternative Names: AL-208; Davunetide IV

Latest Information Update: 27 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Allon Therapeutics
  • Class Antidementias; Eye disorder therapies; Neuropeptides; Neuroprotectants; Nootropics
  • Mechanism of Action Microtubule-associated protein inhibitors; Microtubule-associated protein modulators; Neuropeptide stimulants; Tau protein inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Dementia; Diabetic neuropathies; Eye disorders; Mild cognitive impairment; Stroke

Most Recent Events

  • 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Dementia in USA (IV)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Eye-disorders in Canada (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top